Display options
Share it on

Respir Res. 2021 Jun 10;22(1):177. doi: 10.1186/s12931-021-01769-x.

Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation.

Respiratory research

Aleksandra Wardzyńska, Małgorzata Pawełczyk, Joanna Rywaniak, Joanna Makowska, Joanna Jamroz-Brzeska, Marek L Kowalski

Affiliations

  1. Department of Immunology and Allergy, Medical University of Lodz, Poland ul. Pomorska 251, 92-213, Lodz, Poland. [email protected].
  2. Department of Immunology and Allergy, Medical University of Lodz, Poland ul. Pomorska 251, 92-213, Lodz, Poland.
  3. Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
  4. Department of Rheumatology, Medical University of Lodz, Lodz, Poland.

PMID: 34112152 PMCID: PMC8193882 DOI: 10.1186/s12931-021-01769-x

Abstract

BACKGROUND: The course of asthma may differ between elderly asthmatics (EA) and non-elderly asthmatics (nEA), which may be partially associated with an age-dependent aberrant immune response. The aim of the study was to determine the influence of serum miRNA expression on asthma characteristics and systemic inflammation markers in EA and nEA.

METHODS: Control and severity of asthma, pulmonary function and FeNO were assessed in 28 EA and 31 nEA patients. The control group included 59 elderly and non-elderly healthy individuals. The expression of selected miRNAs in serum was measured with rt-PCR, and proinflammatory cytokine activity was assayed by ELISA or flow cytometry.

RESULTS: No difference in serum miRNA expression was observed between the asthmatics and healthy controls. EA demonstrated lower expression of miRNA-106a and miRNA-126a than nEA (p = 0.003 and p = 0.02) and EC had lower expression of miRNA-146a, -126a, -106a and 19b than nEC (p = 0.001, p = 0.003, p = 0.005 and p < 0.001 respectively). Only nEA demonstrated a relationship between the expression of selected miRNAs and the level of asthma control (assessed with ACT) and with airway inflammation, measured by FeNO level. All patients with asthma demonstrated elevated TNFα, IL-6 and sTNF RI levels compared to controls (p = 0.026, p = 0.03 and p < 0.001 respectively). EA demonstrated a higher TNFα level than EC (p < 0.001), and EA had a higher level of sTNF RI than nEA (p < 0.001). A significant correlation was observed between serum levels of proinflammatory cytokines and selected miRNAs.

CONCLUSION: Serum miRNA expression was found to correlate with clinical characteristics of asthma and systemic inflammation in an age-dependent fashion, suggesting that miRNA may differentially contribute to asthma pathogenesis in elderly and non-elderly patients.

Keywords: Asthma; Basic immunology; Elderly; Innate immunity; Systemic inflammation; miRNA

References

  1. Lancet Respir Med. 2016 Jul;4(7):574-584 - PubMed
  2. Breathe (Sheff). 2016 Mar;12(1):18-28 - PubMed
  3. Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73 - PubMed
  4. J Allergy Clin Immunol. 2020 Jan;145(1):430-433 - PubMed
  5. PLoS One. 2010 May 20;5(5):e10724 - PubMed
  6. Virulence. 2010 Jul-Aug;1(4):295-8 - PubMed
  7. Eur Respir J. 2005 Aug;26(2):319-38 - PubMed
  8. Allergy. 2021 Jun;76(6):1661-1678 - PubMed
  9. J Allergy Clin Immunol. 2014 May;133(5):1429-38, 1438.e1-7 - PubMed
  10. Sci Rep. 2019 Mar 6;9(1):3765 - PubMed
  11. Am J Respir Crit Care Med. 1995 May;151(5):1354-8 - PubMed
  12. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418779243 - PubMed
  13. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18704-9 - PubMed
  14. Geriatr Gerontol Int. 2015 Jul;15(7):902-9 - PubMed
  15. Allergy Asthma Immunol Res. 2020 Jan;12(1):4-23 - PubMed
  16. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9 - PubMed
  17. J Allergy Clin Immunol. 2010 Oct;126(4):690-9; quiz 700-1 - PubMed
  18. J Gerontol A Biol Sci Med Sci. 2015 Jan;70(1):102-9 - PubMed
  19. Aging Cell. 2018 Feb;17(1): - PubMed
  20. PLoS One. 2017 Jun 29;12(6):e0179850 - PubMed
  21. J Investig Allergol Clin Immunol. 2019;29(5):388-389 - PubMed
  22. Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30 - PubMed
  23. Am J Respir Crit Care Med. 2010 Oct 15;182(8):1020-9 - PubMed
  24. J Immunol. 2011 Sep 15;187(6):3362-73 - PubMed
  25. Allergy Asthma Immunol Res. 2020 Jan;12(1):125-136 - PubMed
  26. Clin Interv Aging. 2006;1(3):253-60 - PubMed
  27. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S27-33; discussion S33-40 - PubMed
  28. PLoS One. 2016 Jun 30;11(6):e0157998 - PubMed
  29. Epigenomics. 2019 Feb;11(2):115-131 - PubMed
  30. Respir Res. 2010 Mar 08;11:28 - PubMed
  31. J Biol Chem. 2010 Sep 24;285(39):30139-49 - PubMed
  32. Mol Immunol. 2016 Mar;71:107-114 - PubMed
  33. Arthritis Res Ther. 2008;10(4):R101 - PubMed
  34. Respir Res. 2018 Jun 26;19(1):128 - PubMed
  35. Am J Respir Cell Mol Biol. 2012 Oct;47(4):536-42 - PubMed
  36. Allergy. 2017 Dec;72(12):2035-2038 - PubMed
  37. J Allergy Clin Immunol. 2016 May;137(5):1433-46 - PubMed
  38. Hum Genet. 2020 Mar;139(3):291-308 - PubMed
  39. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6 - PubMed
  40. Clin Invest Med. 2008 Dec 01;31(6):E373-9 - PubMed
  41. PLoS One. 2018 Mar 5;13(3):e0193502 - PubMed
  42. Am J Respir Cell Mol Biol. 2014 Jan;50(1):7-17 - PubMed
  43. Respir Res. 2020 May 7;21(1):107 - PubMed

Publication Types

Grant support